Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

Jie Zhang; Valina L. Dawson; Ted M. Dawson; Solomon H. Snyder

doi:10.1016/S0734-9750(97)88683-1

Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

Jie Zhang, Valina L. Dawson, Ted M. Dawson, Solomon H. Snyder

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

Original language	English (US)
Number of pages	1
Journal	Biotechnology Advances
Volume	15
Issue number	3-4
DOIs	https://doi.org/10.1016/S0734-9750(97)88683-1
State	Published - Jan 1 1997

ASJC Scopus subject areas

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology

Access to Document

10.1016/S0734-9750(97)88683-1

Cite this

@article{4ce0ce1f151f493186c9a1581b74f9d3,

title = "Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity",

abstract = "Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.",

author = "Jie Zhang and Dawson, {Valina L.} and Dawson, {Ted M.} and Snyder, {Solomon H.}",

year = "1997",

month = jan,

day = "1",

doi = "10.1016/S0734-9750(97)88683-1",

language = "English (US)",

volume = "15",

journal = "Biotechnology Advances",

issn = "0734-9750",

publisher = "Elsevier Inc.",

number = "3-4",

}

TY - JOUR

T1 - Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

AU - Zhang, Jie

AU - Dawson, Valina L.

AU - Dawson, Ted M.

AU - Snyder, Solomon H.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

AB - Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

UR - http://www.scopus.com/inward/record.url?scp=0030678980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030678980&partnerID=8YFLogxK

U2 - 10.1016/S0734-9750(97)88683-1

DO - 10.1016/S0734-9750(97)88683-1

M3 - Article

AN - SCOPUS:0030678980

VL - 15

JO - Biotechnology Advances

JF - Biotechnology Advances

SN - 0734-9750

IS - 3-4

ER -

Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this